Microsatellite instability in malignant melanomas

被引:17
|
作者
Kroiss, MM
Vogt, TMM
Schlegel, J
Landthaler, M
Stolz, W [1 ]
机构
[1] Univ Regensburg, Dept Dermatol, D-93042 Regensburg, Germany
[2] Tech Univ Munich, Dept Pathol, D-8000 Munich, Germany
关键词
malignant melanoma; microsatellite instability;
D O I
10.1080/00015550152572840
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Microsatellite instability (NISI) is caused by deficient DNA mismatch: repair, and results in a "mutator" phenotype. Recent studies have produced contradictory results about the frequency and significance of MSI in malignant melanomas. In this study, we therefore determined the time of onset and relative frequency of MSI during the progression of melanocytic tumours, including benign melanocytic naevi. We examined 7 different microsatellite loci in 9 melanocytic nae-vi, 25 primary malignant melanomas and 8 melanoma metastases. None of the melanocytic naevi showed MSI. In contrast, moderate frequency of NISI in 1/12 (8%) was detected in thin melanomas of <0.75mm vertical thickness and in 1/8 (12%) of those with a thickness >0.75 non and <1.5 mm. The rate of NISI was increased in tumours thicker than 1.5 mm (2/5) and in melanoma metastases, with over 25% (2/8) of the lesions investigated. We conclude that NISI occurs in a considerable subset of malignant melanomas and that there is a pattern consistent with increasing frequency of NISI with progression of melanocytic tumours.
引用
收藏
页码:242 / 245
页数:4
相关论文
共 50 条
  • [41] Microsatellite instability in colorectal cancer
    Horvat, Matej
    Stabuc, Borut
    RADIOLOGY AND ONCOLOGY, 2011, 45 (02) : 75 - 81
  • [42] Microsatellite instability in uterine sarcomas
    Amant, F
    Dorfling, CM
    Dreyer, L
    Vergote, I
    Lindeque, BG
    Van Rensburg, EJ
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2001, 11 (03) : 218 - 223
  • [43] Microsatellite instability in endometrial polyps
    Rios, Salete S.
    Andrade, Rosangela V.
    Pereira, Rinaldo W.
    Wall, Nathan R.
    Bahjri, Khaled
    Caldas, Erica
    Cavalcante, Larissa
    Figueiredo, Florencio
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2010, 153 (02) : 193 - 197
  • [44] Frequent chromosomal instability but no microsatellite instability in hepatocellular carcinomas
    Piao, Z
    Kim, H
    Malkhosyan, S
    Park, C
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2000, 17 (03) : 507 - 512
  • [45] ANORECTAL MALIGNANT MELANOMAS: EXPERIENCE OF ULUDAG UNIVERSITY
    Aytac, Berna
    Adim, Saduman Balaban
    Yerci, Omer
    Yilmazlar, Tuncay
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2010, 26 (12) : 658 - 662
  • [46] Cadherin expression in melanocytic naevi and malignant melanomas
    Cowley, GP
    Smith, MEF
    JOURNAL OF PATHOLOGY, 1996, 179 (02) : 183 - 187
  • [47] SENSITIVITY OF CT IN DETECTING MALIGNANT MELANOMAS OF THE CHOROIDEA
    MULLERMINY, H
    POTTER, R
    CLEMENS, S
    KNOCKE, TH
    FORTSCHRITTE AUF DEM GEBIETE DER RONTGENSTRAHLEN UND DER NEUEN BILDGEBENDEN VERFAHREN, 1991, 154 (04): : 425 - 429
  • [48] Fluorescence imaging of cutaneous malignant melanomas and naevi
    Ebert, B
    Kohl, M
    Sukowski, U
    Rinneberg, H
    Winter, H
    Bellmann, KP
    Audring, H
    LASERS IN MEDICAL SCIENCE, 1998, 13 (03) : 204 - 208
  • [49] Low microsatellite instability: A distinct instability type in gastric cancer?
    Meike Kohlruss
    Shounak Chakraborty
    Alexander Hapfelmeier
    Moritz Jesinghaus
    Julia Slotta-Huspenina
    Alexander Novotny
    Leila Sisic
    Matthias M. Gaida
    Katja Ott
    Wilko Weichert
    Nicole Pfarr
    Gisela Keller
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 17727 - 17737
  • [50] Low microsatellite instability: A distinct instability type in gastric cancer?
    Kohlruss, Meike
    Chakraborty, Shounak
    Hapfelmeier, Alexander
    Jesinghaus, Moritz
    Slotta-Huspenina, Julia
    Novotny, Alexander
    Sisic, Leila
    Gaida, Matthias M.
    Ott, Katja
    Weichert, Wilko
    Pfarr, Nicole
    Keller, Gisela
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (20) : 17727 - 17737